In diabetic patients with preserved EF, canagliflozin has proven to reduce the E/e ratio, a marker of diastolic dysfunction, after 3 months of treatment.40 In a small study including diabetic patients with established CV disease,41 empagliflozin led to reductions in the ventricular mass and significant improvements in diastolic function on tissue Doppler, also at 3 months
When factoring in the risk of research disruption, the "cheaper" option often ends up costing more in practical terms
A., InheritanceSpecific Dysregulation of Th1 and Th17Associated Cytokines in Alopecia Areata, Biomolecules 13, no
Serving Stamford, Connecticut and surrounding New York, Connecticut, and New England communities, Jennifer Jose-Cappola, MD delivers modern longevity care focused on energy, resilience, and extended quality of life